Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inamed was a leading global healthcare company focused on developing, manufacturing, and marketing innovative products for the aesthetic and bariatric markets. The company's portfolio included breast implants, dermal fillers, and the Lap-Band System for obesity intervention. In 2006, Inamed was acquired by Allergan for approximately $3.2 billion, significantly expanding Allergan's presence in the medical aesthetics industry. Today, many of Inamed's legacy products, such as Juvéderm and Natrelle, remain market leaders under the Allergan Aesthetics brand. The acquisition was a pivotal moment in the consolidation of the aesthetics sector, creating a powerhouse in facial and body contouring. Inamed's contributions to silicone gel technology and hyaluronic acid fillers continue to influence the standard of care in plastic surgery and dermatology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inamed Aesthetics.